Identification and characterization of inhibitors of cytoplasmic 5′-nucleotidase cN-II issued from virtual screening-Reference-Cited by-同舟云学术

Identification and characterization of inhibitors of cytoplasmic 5′-nucleotidase cN-II issued from virtual screening

Published:2013-02 Issue:4 Volume:85 Page:497-506
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Jordheim Lars Petter,Marton Zsuzsanna,Rhimi Moez,Cros-Perrial Emeline,Lionne Corinne,Peyrottes Suzanne,Dumontet Charles,Aghajari Nushin,Chaloin Laurent

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference31 articles.

1. Mammalian 5’-nucleotidases;Bianchi;J Biol Chem,2003

2. Regulation and activity of cytosolic 5’-nucleotidase II. A bifunctional allosteric enzyme of the haloacid dehalogenase superfamily involved in cellular metabolism;Bretonnet;FEBS Lett,2005

3. Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances;Rampazzo;Mutat Res,2010

4. Active and regulatory sites of cytosolic 5’-nucleotidase;Pesi;FEBS J,2010

5. ATP and phosphate reciprocally affect subunit association of human recombinant high Km 5’-nucleotidase. Role for the C-terminal polyglutamic acid tract in subunit association and catalytic activity;Spychala;Eur J Biochem,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico approaches for drug repurposing in oncology: a scoping review;Frontiers in Pharmacology;2024-06-11

2. Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A systematic review;PLOS ONE;2024-05-22

3. Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia;Cancer Discovery;2022-08-19

4. Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines;Cells;2021-10-28

5. Cytotoxic and antitumoral activity of N-(9H-purin-6-yl) benzamide derivatives and related water-soluble prodrugs;Current Molecular Pharmacology;2021-10-14